784 filings
Page 13 of 40
4
Christopher D Galloway
21 Oct 20
Diffusion Pharmaceuticals / CHRISTOPHER D GALLOWAY ownership change
8:04pm
3
CRVO
CervoMed Inc
21 Oct 20
Diffusion Pharmaceuticals / CHRISTOPHER D GALLOWAY ownership change
7:49pm
8-K
CRVO
CervoMed Inc
20 Oct 20
Diffusion Pharmaceuticals Appoints Dr. Chris Galloway as Chief Medical Officer
5:30pm
4
CRVO
CervoMed Inc
14 Oct 20
Diffusion Pharmaceuticals / WILLIAM ROBERT ELDER ownership change
7:40pm
3
William Robert Elder
14 Oct 20
Diffusion Pharmaceuticals / WILLIAM ROBERT ELDER ownership change
7:27pm
8-K
CRVO
CervoMed Inc
9 Oct 20
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:16pm
EFFECT
CRVO
CervoMed Inc
5 Oct 20
Notice of effectiveness
12:21am
424B2
CRVO
CervoMed Inc
2 Oct 20
Prospectus for primary offering
4:16pm
4
CRVO
CervoMed Inc
1 Oct 20
Diffusion Pharmaceuticals / Jane H Hollingsworth ownership change
8:29pm
3
Jane H Hollingsworth
1 Oct 20
Diffusion Pharmaceuticals / Jane H Hollingsworth ownership change
8:22pm
CORRESP
CRVO
CervoMed Inc
30 Sep 20
Correspondence with SEC
12:00am
UPLOAD
CRVO
CervoMed Inc
29 Sep 20
Letter from SEC
12:00am
8-K
CRVO
CervoMed Inc
25 Sep 20
Diffusion Pharmaceuticals Strengthens Management Team with Appointmentof William Elder as General Counsel and Corporate Secretary
4:57pm
S-3
CRVO
CervoMed Inc
Shelf registration
25 Sep 20
4:06pm
8-K
CRVO
CervoMed Inc
15 Sep 20
Regulation FD Disclosure
2:50pm
4
Cobuzzi Robert Joseph Jr.
11 Sep 20
Diffusion Pharmaceuticals / Robert Joseph Jr. Cobuzzi ownership change
6:56pm
8-K
CRVO
CervoMed Inc
10 Sep 20
Other Events
4:39pm
8-K
CRVO
CervoMed Inc
9 Sep 20
Diffusion Pharmaceuticals Names Director Dr. Robert Cobuzzi as President and Chief Executive Officer
9:30am
8-K
CRVO
CervoMed Inc
4 Sep 20
Diffusion Pharmaceuticals Appoints
4:01pm
8-K
CRVO
CervoMed Inc
10 Aug 20
Diffusion Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Business Update
5:00pm